Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
Chemours: Q4 Earnings Snapshot
Chemours: Q4 Earnings Snapshot
Associated Press Finance
Fri, February 20, 2026 at 6:52 AM GMT+9 1 min read
In this article:
CC
-3.50%
WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Chemours Co. (CC) on Thursday reported a loss of $47 million in its fourth quarter.
On a per-share basis, the Wilmington, Delaware-based company said it had a loss of 31 cents. Earnings, adjusted for non-recurring costs, came to 5 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.
The chemical company posted revenue of $1.33 billion in the period, which met Street forecasts.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on CC at
Terms and Privacy Policy
Privacy Dashboard
More Info